Alterations of pituitary adenylate cyclase-activatinq polypeptide-like immunoreactivity in the human plasma during pregnancy and after birth

D. Reglodi, J. Gyarmati, T. Ertl, R. Borzsei, J. Bodis, A. Tamás, P. Kiss, K. Csanaky, E. Banki, C. Bay, J. Németh, Z. Helyes

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Since its discovery, several distinct effects of pituitary adenylate cyclase activating polypeptide (PACAP) have been established - predominantly in animal studies - in the nervous system, various peripheral organs as well as in the endocrine regulation. It is unknown whether PACAP has any effect on human pregnancy regarding either utero-maternal or perinatal aspects of the gestation. Aim: We investigated alterations of PACAP38-like immunoreactivity (PACAP38-LI) in the human plasma throughout normal pregnancy, during and after delivery, and its level in the umbilical vessels, as well as in the peripheral blood of term healthy newborns. Materials and methods: A 2 ml blood sample was used for each test, PACAP38-LI was determined by radioimmunoassay. Results: In the 2nd and 3rd trimester significant elevation was observed in the PACAP38-LI compared to the earlier gestation and non-pregnant conditions. During delivery its level significantly decreased and returned to the original values 3 days after birth. In the neonates PACAP38-LI level of the peripheral blood was similar to that of healthy adults, but umbilical arteries and veins contained significantly lower concentrations of PACAP38-LI. Besides, the levels were lower in the umbilical vein compared to the artery. Conclusions: PACAP38-LI levels show sensitive change during normal pregnancy and delivery. Our findings suggest that the fetal organs actively synthesize PACAP. Further investigations are required to elucidate the physiological importance of the alterations observed.

Original languageEnglish
Pages (from-to)443-445
Number of pages3
JournalJournal of Endocrinological Investigation
Volume33
Issue number7
Publication statusPublished - Jul 2010

Fingerprint

Pituitary Adenylate Cyclase-Activating Polypeptide
Adenylyl Cyclases
Parturition
Pregnancy
Peptides
Umbilical Veins
Newborn Infant
Umbilicus
Umbilical Arteries
Peripheral Nervous System
varespladib methyl
Radioimmunoassay
Arteries
Mothers

Keywords

  • Delivery
  • Newborn
  • PACAP
  • RIA
  • Umbilical vessels

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Alterations of pituitary adenylate cyclase-activatinq polypeptide-like immunoreactivity in the human plasma during pregnancy and after birth. / Reglodi, D.; Gyarmati, J.; Ertl, T.; Borzsei, R.; Bodis, J.; Tamás, A.; Kiss, P.; Csanaky, K.; Banki, E.; Bay, C.; Németh, J.; Helyes, Z.

In: Journal of Endocrinological Investigation, Vol. 33, No. 7, 07.2010, p. 443-445.

Research output: Contribution to journalArticle

@article{03d5c787608c49d6b85ff10e2794b70a,
title = "Alterations of pituitary adenylate cyclase-activatinq polypeptide-like immunoreactivity in the human plasma during pregnancy and after birth",
abstract = "Background: Since its discovery, several distinct effects of pituitary adenylate cyclase activating polypeptide (PACAP) have been established - predominantly in animal studies - in the nervous system, various peripheral organs as well as in the endocrine regulation. It is unknown whether PACAP has any effect on human pregnancy regarding either utero-maternal or perinatal aspects of the gestation. Aim: We investigated alterations of PACAP38-like immunoreactivity (PACAP38-LI) in the human plasma throughout normal pregnancy, during and after delivery, and its level in the umbilical vessels, as well as in the peripheral blood of term healthy newborns. Materials and methods: A 2 ml blood sample was used for each test, PACAP38-LI was determined by radioimmunoassay. Results: In the 2nd and 3rd trimester significant elevation was observed in the PACAP38-LI compared to the earlier gestation and non-pregnant conditions. During delivery its level significantly decreased and returned to the original values 3 days after birth. In the neonates PACAP38-LI level of the peripheral blood was similar to that of healthy adults, but umbilical arteries and veins contained significantly lower concentrations of PACAP38-LI. Besides, the levels were lower in the umbilical vein compared to the artery. Conclusions: PACAP38-LI levels show sensitive change during normal pregnancy and delivery. Our findings suggest that the fetal organs actively synthesize PACAP. Further investigations are required to elucidate the physiological importance of the alterations observed.",
keywords = "Delivery, Newborn, PACAP, RIA, Umbilical vessels",
author = "D. Reglodi and J. Gyarmati and T. Ertl and R. Borzsei and J. Bodis and A. Tam{\'a}s and P. Kiss and K. Csanaky and E. Banki and C. Bay and J. N{\'e}meth and Z. Helyes",
year = "2010",
month = "7",
language = "English",
volume = "33",
pages = "443--445",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "7",

}

TY - JOUR

T1 - Alterations of pituitary adenylate cyclase-activatinq polypeptide-like immunoreactivity in the human plasma during pregnancy and after birth

AU - Reglodi, D.

AU - Gyarmati, J.

AU - Ertl, T.

AU - Borzsei, R.

AU - Bodis, J.

AU - Tamás, A.

AU - Kiss, P.

AU - Csanaky, K.

AU - Banki, E.

AU - Bay, C.

AU - Németh, J.

AU - Helyes, Z.

PY - 2010/7

Y1 - 2010/7

N2 - Background: Since its discovery, several distinct effects of pituitary adenylate cyclase activating polypeptide (PACAP) have been established - predominantly in animal studies - in the nervous system, various peripheral organs as well as in the endocrine regulation. It is unknown whether PACAP has any effect on human pregnancy regarding either utero-maternal or perinatal aspects of the gestation. Aim: We investigated alterations of PACAP38-like immunoreactivity (PACAP38-LI) in the human plasma throughout normal pregnancy, during and after delivery, and its level in the umbilical vessels, as well as in the peripheral blood of term healthy newborns. Materials and methods: A 2 ml blood sample was used for each test, PACAP38-LI was determined by radioimmunoassay. Results: In the 2nd and 3rd trimester significant elevation was observed in the PACAP38-LI compared to the earlier gestation and non-pregnant conditions. During delivery its level significantly decreased and returned to the original values 3 days after birth. In the neonates PACAP38-LI level of the peripheral blood was similar to that of healthy adults, but umbilical arteries and veins contained significantly lower concentrations of PACAP38-LI. Besides, the levels were lower in the umbilical vein compared to the artery. Conclusions: PACAP38-LI levels show sensitive change during normal pregnancy and delivery. Our findings suggest that the fetal organs actively synthesize PACAP. Further investigations are required to elucidate the physiological importance of the alterations observed.

AB - Background: Since its discovery, several distinct effects of pituitary adenylate cyclase activating polypeptide (PACAP) have been established - predominantly in animal studies - in the nervous system, various peripheral organs as well as in the endocrine regulation. It is unknown whether PACAP has any effect on human pregnancy regarding either utero-maternal or perinatal aspects of the gestation. Aim: We investigated alterations of PACAP38-like immunoreactivity (PACAP38-LI) in the human plasma throughout normal pregnancy, during and after delivery, and its level in the umbilical vessels, as well as in the peripheral blood of term healthy newborns. Materials and methods: A 2 ml blood sample was used for each test, PACAP38-LI was determined by radioimmunoassay. Results: In the 2nd and 3rd trimester significant elevation was observed in the PACAP38-LI compared to the earlier gestation and non-pregnant conditions. During delivery its level significantly decreased and returned to the original values 3 days after birth. In the neonates PACAP38-LI level of the peripheral blood was similar to that of healthy adults, but umbilical arteries and veins contained significantly lower concentrations of PACAP38-LI. Besides, the levels were lower in the umbilical vein compared to the artery. Conclusions: PACAP38-LI levels show sensitive change during normal pregnancy and delivery. Our findings suggest that the fetal organs actively synthesize PACAP. Further investigations are required to elucidate the physiological importance of the alterations observed.

KW - Delivery

KW - Newborn

KW - PACAP

KW - RIA

KW - Umbilical vessels

UR - http://www.scopus.com/inward/record.url?scp=77957259260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957259260&partnerID=8YFLogxK

M3 - Article

C2 - 20671407

AN - SCOPUS:77957259260

VL - 33

SP - 443

EP - 445

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 7

ER -